Primecap Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Sell |
1,027,620
-237,000
| -19% | -$275K | ﹤0.01% | 315 |
|
|
2025
Q1 | $2.01M | Sell |
1,264,620
-256,010
| -17% | -$407K | ﹤0.01% | 303 |
|
|
2024
Q4 | $4.61M | Buy |
1,520,630
+22,600
| +2% | +$68.5K | ﹤0.01% | 278 |
|
|
2024
Q3 | $5.51M | Buy |
1,498,030
+265,690
| +22% | +$978K | ﹤0.01% | 282 |
|
|
2024
Q2 | $5.04M | Buy |
1,232,340
+67,730
| +6% | +$277K | ﹤0.01% | 279 |
|
|
2024
Q1 | $18.4M | Buy |
1,164,610
+141,260
| +14% | +$2.23M | 0.01% | 231 |
|
|
2023
Q4 | $15.5M | Sell |
1,023,350
-10,400
| -1% | -$158K | 0.01% | 241 |
|
|
2023
Q3 | $20.7M | Sell |
1,033,750
-77,400
| -7% | -$1.55M | 0.02% | 229 |
|
|
2023
Q2 | $31.3M | Sell |
1,111,150
-17,770
| -2% | -$501K | 0.03% | 207 |
|
|
2023
Q1 | $19.4M | Sell |
1,128,920
-1,250
| -0.1% | -$21.5K | 0.02% | 228 |
|
|
2022
Q4 | $22.8M | Sell |
1,130,170
-49,530
| -4% | -$998K | 0.02% | 212 |
|
|
2022
Q3 | $25.6M | Sell |
1,179,700
-12,300
| -1% | -$266K | 0.02% | 202 |
|
|
2022
Q2 | $33.5M | Sell |
1,192,000
-16,590
| -1% | -$466K | 0.03% | 192 |
|
|
2022
Q1 | $55.8M | Sell |
1,208,590
-45,050
| -4% | -$2.08M | 0.04% | 179 |
|
|
2021
Q4 | $105M | Sell |
1,253,640
-81,980
| -6% | -$6.89M | 0.07% | 157 |
|
|
2021
Q3 | $89M | Sell |
1,335,620
-12,990
| -1% | -$866K | 0.06% | 160 |
|
|
2021
Q2 | $71.7M | Buy |
1,348,610
+13,180
| +1% | +$701K | 0.05% | 176 |
|
|
2021
Q1 | $57.9M | Sell |
1,335,430
-36,260
| -3% | -$1.57M | 0.04% | 185 |
|
|
2020
Q4 | $71.2M | Sell |
1,371,690
-11,060
| -0.8% | -$574K | 0.05% | 169 |
|
|
2020
Q3 | $45.2M | Buy |
1,382,750
+722,800
| +110% | +$23.6M | 0.04% | 171 |
|
|
2020
Q2 | $31.7M | Buy |
+659,950
| New | +$31.7M | 0.03% | 184 |
|